![Michael Bailey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Bailey
Chairman at
IMV INC.
Net worth: 869 400 $ as of 29/09/2026
Profile
Mr. Michael P.
Bailey is a Chairman at IMV, Inc. He is on the Board of Directors at Verastem, Inc. and AVEO Pharmaceuticals, Inc. Mr. Bailey was previously employed as a Chief Commercial Officer & Senior Vice President by Synta Pharmaceuticals Corp., a Senior Vice President-Commercial Operations by ImClone Systems, Inc., and a Member-Global Commercial Partnership Teams by Genentech, Inc. He received his undergraduate degree from St. Lawrence University and an MBA from Mendoza College of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VERASTEM, INC. 0.18% | 20/05/2026 | 108,000 ( 0.18% ) | 869 400 $ | 29/09/2026 |
Michael Bailey active positions
| Companies | Position | Start |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Director/Board Member | 29/06/2026 |
| IMV INC. | Chairman | 30/04/2022 |
| VERASTEM, INC. | Director/Board Member | 25/05/2026 |
Former positions of Michael Bailey
| Companies | Position | End |
|---|---|---|
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Corporate Officer/Principal | 06/09/2010 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Corporate Officer/Principal | 31/07/2008 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Education of Michael Bailey
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
64
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Health Technology |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
St. Lawrence University
 St. Lawrence University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IMV, Inc.
 IMV, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Mendoza College of Business
 Mendoza College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Michael Bailey
